RecruitingNCT07258329

Screening for Intrapartum Fetal Compromise Using Placental Biomarkers

Screening Della Compromissione Fetale Intrapartum Mediante Utilizzo Dei Marcatori Placentari

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

428 participants

Start Date

Mar 28, 2025

Study Type

OBSERVATIONAL

Conditions

Pregnant women

Summary

This study aims to investigate the association between placental markers (sFlt-1, PlGF, and the sFlt-1/PlGF ratio) and intrapartum fetal compromise, assessed on the basis of the cardiotocographic tracing.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with pregnant women. The study is currently recruiting participants at 2 locations. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.